Condition: Diffusion Magnetic Resonance Imaging · Brain White Matter Diseases · Sponsor: The General Authority for Teaching Hospitals and Institutes
To assess the sensitivity and accuracy of diffusion magnetic resonance imaging (MRI), including diffusion-weighted imaging (DWI) metrics, in identifying early-stage changes in brain white matter related to various white matter diseases.
This description comes directly from the study's public registry record.
Hekmat S Baumey, MD · 00201555433546 · hekmattsamir@gmail.com
Always discuss trial participation with your own doctor first.
| General Authority for Teaching Hospitals and Institutes | Cairo, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07108712